EP3655075B1 - Nebulization device for medical mixture - Google Patents
Nebulization device for medical mixture Download PDFInfo
- Publication number
- EP3655075B1 EP3655075B1 EP18739559.5A EP18739559A EP3655075B1 EP 3655075 B1 EP3655075 B1 EP 3655075B1 EP 18739559 A EP18739559 A EP 18739559A EP 3655075 B1 EP3655075 B1 EP 3655075B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nebulization device
- shielding
- ampoule
- selector
- command shaft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002663 nebulization Methods 0.000 title claims description 61
- 239000011873 medical mixture Substances 0.000 title claims description 7
- 239000003708 ampul Substances 0.000 claims description 27
- 230000008878 coupling Effects 0.000 claims description 13
- 238000010168 coupling process Methods 0.000 claims description 13
- 238000005859 coupling reaction Methods 0.000 claims description 13
- 210000002345 respiratory system Anatomy 0.000 description 10
- 239000002245 particle Substances 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000001033 granulometry Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 210000003456 pulmonary alveoli Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
- A61M15/0015—Details of inhalators; Constructional features thereof with inhalation check valves located upstream of the dispenser, i.e. not traversed by the product
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0018—Details of inhalators; Constructional features thereof with exhalation check valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
Definitions
- European patent application n° EP 2 952 219A1 to 3A Health Care S.r.l. provides for a displacement of the air intake duct within the nebulization device, in order to vary the relative position thereof with respect to the atomizer from which pressurized gas is introduced.
- a nebulization device for medical mixture of the type comprising a containing ampoule for the medical mixture, at least one atomizer for the intake of pressurized gas within said ampoule, at least one emission opening of said nebulized medical mixture and at least one window for the intake of air from outside.
- the atomizer is surmounted by an upper portion of the ampoule.
- At least one, preferably two selection side windows are further provided on the wall of the upper portion of the ampoule, whose opening is shielded by shielding means.
- the command shaft extends along the central axis of the duct.
- the lower component 2b preferably is also shaped as a circular section. Said lower component 2b preferably has an ergonomic profile externally, which facilitates the grip by the patient during the therapy.
- the lower component 2b further has an open end 6 within which the coupling with the upper component 2a occurs.
- the invention does not provide any movement of the duct for the intake of air within the nebulization device to vary the relative position thereof with respect to the atomizer from which the intake of pressurized gas occurs, but just a relative movement of the shielding means 16 with respect to the atomizer 14.
- the valve system 25 works synergistically with a valve 26 present on the mouthpiece 13.
- the three illustrated selection positions correspond, in this case, to:
- the greater or smaller dimension of the flow area and therefore the greater or lesser consistency of the air flow affects both the delivery speed and the size of the aerosol particles generated by the ampoule 2.
- the nebulization device 1 is completely disassemblable. Therefore, the practicality of the cleaning, disinfection and sterilization phases of the nebulization device 1 components is improved.
- embedded, hidden or difficult to reach components are not present, as above described. In this way the hygiene required for a medical device and the prevention of the proliferation of germs, bacteria and viruses are ensured.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Nozzles (AREA)
Description
- The present invention relates to a portable nebulization device for medical fluids, and in particular to a universal nebulization device, optimized for the treatment of all of the tracts of a patient's respiratory system.
- The above nebulization apparatus finds useful application in the medical field, particularly in the aerosol therapy field.
- The administration of drugs by air tract through appropriate nebulizing devices is a therapeutic practice usually employed in relation to numerous diseases, especially of the respiratory apparatus.
- In particular, nebulization allows dividing a drug in the liquid form into a plurality of very fine particles, having a diameter of a few micrometers, which can be easily inhaled by a patient.
- It is also known that for the treatment of the various tracts of the respiratory system a specific nebulization is necessary.
- Indeed, in order for the nebulized particles to be able to reach differently the upper respiratory tract, the tracheo-bronchial tract or the pulmonary alveoli a different sizing is needed.
- In fact, for a treatment involving the first respiratory tract a coarser nebulization is recommended, whereas for the deeper respiratory tracts a very fine nebulization is essential.
- The optimal granulometry for the treatment of the specific respiratory tracts is indicated in the bibliography and in the specific UNI EN 13544-1 standard, which specifies that:
- a diameter greater than 5 µm allows a deposition in the upper respiratory tract;
- a diameter comprised between 2 µm and 6 µm allows a deposition in the tracheo-bronchial tract;
- a diameter comprised between 0.5 µm and 3 µm allows a deposition at the level of the pulmonary alveoli.
- In order to obtain a granulometry suitable for the various needs above listed, the most adopted solution has been that of using specific components for each purpose.
- In particular, within a known configuration of a nebulization device, more atomizers have been provided, from which pressurized gas is introduced (also called "pisper").
- According to the adopted atomizer, there is indeed a more or less fine nebulization of the medical liquid.
- This type of solution allows obtaining the undoubted advantage of providing precise dimensional atomization values for all needs.
- However, it is equally clear that this solution also implies the drawback of being more difficult to be used.
- In fact, it is necessary for the patient to have a minimum competence in choosing the correct atomizer in own specific case. This clearly involves the inherent risk of an incorrect choice of the atomizer.
- To this drawback those of lack of practicality due to the need for replacement and to keep a greater quantity of components of the nebulization device with the risk of loss when not used are added.
- For this reason, devices allowing a geometric positioning variation of the same components to obtain a different nebulization have also been provided.
- For instance, European patent application n°
EP 2 952 219A1 - Although this solution allows an advantage for the different nebulization obtained based on the relative position between the two above mentioned components, it also has drawbacks from an operation point of view.
- In fact, due to the structural complexity, it does not allow a correct disassembling among the nebulization device components and a consequent inadequate cleaning/ disinfection/ sterilization.
- In fact, we wish torecall that, since the nebulization devices are used for patients suffering from lung infections, all the components adopted must ensure a certain level of sterilization, so as not to further worsen said infection.
- Another known technical solution is disclosed in US patent application n°
US 3,658,059 A , which relates to an inhaler provided with a diaphragm to change the effective size of the passage suitable for making the suspension to be inhaled pass. The diaphragm is moved towards and away from the inhaler jet, in order to increase or reduce the opening. Though advantageous under various aspects, this solution does not allow a simple disassembling of the components to favour the cleaning and sterilization thereof. - A further known solution is described in European patent application n°
EP 3 017 839 A1 - An object of the present invention is to provide a nebulization device that allows obtaining a different granulometry of the particles according to the needs of the specific patient, without replacing the components.
- A further object is to provide the total disassembling of the nebulization device to allow the correct cleaning/disinfection/sterilization of the adopted components.
- Another object is to provide a nebulization device of practical use, even by not particularly experienced patients.
- Finally, a further object is to provide a nebulization device that is structurally simple so as to avoid constructive problems which are not suitable for a product intended for mass production.
- The solution idea underlying the present invention is to provide a nebulization device that allows the intake of air from outside in different quantities according to the needed granulometry to obtain.
- The above technical problem is solved by a nebulization device for medical mixture, of the type comprising a containing ampoule for the medical mixture, at least one atomizer for the intake of pressurized gas within said ampoule, at least one emission opening of said nebulized medical mixture and at least one window for the intake of air from outside. The atomizer is surmounted by an upper portion of the ampoule. At least one, preferably two selection side windows are further provided on the wall of the upper portion of the ampoule, whose opening is shielded by shielding means. Said shielding means are axially moved, precisely allowing the shielding, by a command shaft thereto connected and by a shielding selector coupled and linked to a control knob connected to said command shaft such to control the flow coming from the atomizer; the coupling between said control shaft and said shielding selector being obtained by a threaded coupling.
- According to a preferred embodiment, the shielding means are comprised in a skirt-shaped shielding selector which the shaft is connected to.
- Furthermore, according to a preferred embodiment, the command shaft extends along the central axis of the duct.
- According to another aspect of the invention, the shielding means consist in at least two bulkheads which extend parallel to the command shaft at the selection side windows.
- According to another aspect of the invention, the nebulization device further comprises a control knob at an end of the command shaft in order to vary the position along the axis of the shaft itself through a rotary-translational movement.
- According to a further aspect of the invention, the rotary-translational movement of said control knob that moves the command shaft is obtained through a cam groove obtained on an inner wall of the ampoule within which the control knob moves.
- Alternatively, according to another embodiment of the invention, a wide-radius external thread is provided on the outer surface of the command shaft, external thread that engages with a corresponding inner thread of a threaded portion of the shielding selector.
- According to a second embodiment of the present invention, the shielding selector comprises two additional entry windows for the intake of air within said ampoule.
- According to a further aspect of the invention, the nebulization device further comprises at least two valves at a base of said control knob for the variation of air flow into the inhalation and exhalation phases.
- Still according to another aspect of the present invention, the nebulization device provides a mouthpiece at the emission outlet for the connection with the patient's air tracts.
- Furthermore, according to an aspect of the invention, the ampoule is made of two pieces interconnected to each other.
- Further features and advantages will become clearer from the following detailed description of a preferred, but not exclusive, embodiment of the present invention, with reference to the appended figures given by way of non-limiting example.
- In said drawings:
-
Figure 1 represents an exploded view of an embodiment of the nebulization device according to the invention; -
Figures 2a, 2b and 2c represent sectional views of the three operating positions of the nebulization device offigure 1 ; -
Figures 3a, 3b, 3c and 3d represent sectional views of the valve system and of the nozzle of the nebulization device offigure 1 ; -
Figure 4 represents an exploded view of a second embodiment of the nebulization device according to the invention; -
Figures 5a, 5b and 5c represent sectional views of the three operating positions of the nebulization device offigure 4 ; -
Figures 6a, 6b, 6c and 6d represent sectional views of the valve system and of the nozzle of the nebulization device offigure 1 ; -
Figures 7a and 7b show the sectional views of a third embodiment of a nebulization device according to the invention; -
Figures 8a, 8b and 8c show an exploded view of a fourth embodiment of a nebulization device according to the invention; -
Figures 9a, 9b and 9c show an exploded view of a variant of the embodiment ofFigures 8a, 8b and 8c . - With reference to the figures, and particularly to
figure 1 ,reference number 1 globally and schematically indicates a nebulization device realized according to the present invention. - Said
nebulization device 1 is illustrated in the Figures arranged vertically, according to a preferred operating configuration. In the following of the present invention, the positions and orientations, relative and absolute, of the various elements which the device is made of, defined by means of terms such as upper and lower, on and under, horizontal and vertical or other equivalent terms, will be expressed with reference to said configuration without them representing a limitation of the Applicant's rights. - The
nebulization device 1 comprises anampoule 2, preferably divided into two components, anupper component 2a and alower component 2b, respectively. - The
upper component 2a is preferably shaped as a circular section with anupper portion 3, having a larger diameter, and alower portion 4, having a smaller diameter, which are connected to each other by a truncated-conical portion 5. - The
lower component 2b preferably is also shaped as a circular section. Saidlower component 2b preferably has an ergonomic profile externally, which facilitates the grip by the patient during the therapy. Thelower component 2b further has anopen end 6 within which the coupling with theupper component 2a occurs. - Preferably, at a
side surface 10 of thecomponent 2b, there is anopening 11 from which aduct segment 12 departs, which is preferably inclined by an angle with respect to a cross-section of thelower component 2b. - The
duct segment 12 is shaped so as to couple to a connection device with the patient's air tracts, such as, for instance, amouthpiece 13. - Nothing forbids adopting other connection devices with the patient's air tracts, such as the known nasal masks or forks.
- At an
end 7 opposite theopen end 6, there is aclosing surface 8, which is glass-shaped and comprising a nozzle-duct 9. - On the nozzle-
duct 9 an atomizer 14 (also known in the art with the name of "pisper") is fitted. - Said
atomizer 14 is surmounted by thelower portion 4 of theupper component 2a. - Between such a
lower portion 4 and the atomizer 14 a shieldingselector 15, which is preferably skirt-shaped, comprising at least one, preferably two, shielding means 16, is interposed. Said shielding means preferably consist in two bulkheads that develop parallel according to the longitudinal development of theampoule 2. Furthermore, said shielding means 16 are preferably circumference-arc shaped. - Differently from the prior art, the invention does not provide any movement of the duct for the intake of air within the nebulization device to vary the relative position thereof with respect to the atomizer from which the intake of pressurized gas occurs, but just a relative movement of the shielding means 16 with respect to the
atomizer 14. - The shielding means 16, according to the position along the axis, can control the flow coming from the
atomizer 14. The shieldingselector 15 is connected at anend 32 of thecommand shaft 17 which controls the movement thereof. - The
command shaft 17, preferably provided along the longitudinal transversal axis of theampoule 2, slides longitudinally, precisely moving the shieldingselector 15. - At the
opposite end 33 of thecommand shaft 17 and connected thereto acontrol knob 18 is preferably provided. - It is possible to provide for the
control knob 18 to be integrally formed with thecommand shaft 17. - The shielding
selector 15 is coupled and linked to thecontrol knob 18 connected to saidcommand shaft 17; the coupling between saidcommand shaft 17 and said shieldingselector 15 being obtained by a threaded coupling; for instance, a worm screw coupling. - The
control knob 18 has a circular section, with a grippingportion 29 along a diameter thereof, ergonomically shaped to facilitate the rotation of thecontrol knob 18. - The
control knob 18, at the sides of the grippingportion 29, is crossed by at least one, preferably twoentry windows 19, through which there is the intake of external air within theampoule 2. - The
control knob 18 provides acam groove 21 on theouter surface 20. - The
cam groove 21 is engaged by corresponding engagingpins 22 arranged at aninner surface 23 of theupper portion 3 of theupper component 2a. - At the
lower portion 4 of theupper component 2a, at least one, preferably two,selection side windows 24 are obtained. Below saidselection side windows 24 there is alower portion sector 4 having height H. The twowindows 24 are preferably provided on diametrically opposite parts. - Said
selection side windows 24 can be totally, partially or not at all obstructed by the shielding means 16, as it can be seen infigures 2a, 2b and 2c , respectively. - Immediately contiguous to the
control knob 18, at theentry windows 19, avalve system 25 is provided. - The valve system can be more evident in
figures 3a, 3b and 3c . - The
valve system 25 works synergistically with avalve 26 present on themouthpiece 13. - In particular, in
Figures 3b and 3c respectively, the closing and opening conditions of thevalve system 25 are represented. - The
valve system 25 of the present embodiment comprises two valves which open in the inhalation phase. In this phase, on the contrary, the closing of thevalve 26 arranged on themouthpiece 13 occurs. Vice versa, in the exhalation phase the closing of the valves of thevalve system 25 and the opening of thevalve 26 on themouthpiece 13 occur. - Instead, in
Figure 3d an enlarged section of the functional coupling between thenozzle duct 9, theatomizer 14 and the shieldingselector 15 is highlighted. - In
Figure 4 a second embodiment of the present invention is represented. - Said embodiment differs from the embodiment represented in
Figure 1 in the presence of twoadditional entry windows 27 on the shieldingselector 15, close to the coupling with thecommand shaft 17. - Another difference of this embodiment with respect to the embodiment of
Figure 1 is represented by the absence of the truncated-conical portion 5 between theupper portion 3 and thelower portion 4 of theupper component 2a of theampoule 2. Instead of this truncated-conical portion 5, an immediate reduction in section between theupper portion 3 and thelower portion 4 is provided at across-section 28. - The
lower portion 4 of theupper component 2a of theampoule 2 is therefore longer with respect to the first embodiment of the invention. - A further difference of this embodiment with respect to the one represented in
Figure 1 is represented by thevalve system 25. In fact, instead of the two valves of the first embodiment, aunique baffle 30 is provided. - It is possible to see in detail the different valve system of the second embodiment in
Figures 6a, 6b and 6c . - The
baffle 30 operates analogously to the valves of the first embodiment. In fact, a deformation thereof inwards allows the air flow in the inhalation phase, when the correspondingvalve 26 on themouthpiece 13 is closed. Instead, in the exhalation phase thebaffle 30 returns to a rectilinear conformation, thus occluding theentry windows 19, whereas the opening of thevalve 26 occurs on themouthpiece 13. - Instead, in
Figure 6d an enlarged section of the functional coupling between thenozzle duct 9, theatomizer 14 and the shieldingselector 15 is highlighted. - Since the
valve system 25 is particularly complex and, consequently expensive, a third embodiment represented inFigures 7a and 7b is provided. - In said Figures it can be noticed that the valve system is replaced by a
virtual valve system 37. Saidvirtual valve system 37 is obtained through a different conformation of theentry windows 19. In fact, instead of housing valves,such entry windows 19 have a "wolf-mouth" section, which is sufficient to ensure the correct delivery of the nebulized and meanwhile to properly obstruct the discharge of the flow exhaled by the patient. In this way said exhaled flow is free to vent through the side windows of the mouthpiece, which is also devoid of a valve. - A fourth embodiment is also provided, which is realized as an alternative adjustment mode through the shielding
selector 15. - According to said embodiment, the shielding
selector 15 is provided with a threadedportion 34 protruding upwards, which is provided with aninner thread 35, which is at least a single-start-thread. - Said
inner thread 35 is engaged by at least one wide-radiusexternal thread 36 obtained on anexternal surface 38 of thecommand shaft 17. - As a result, the above-mentioned adjustment of the shielding
selector 15 is obtained through a rotary movement of thecommand shaft 17 within the threadedportion 34 of the shieldingselector 15 itself. - Therefore, engaging
pins 22 sliding in acam groove 21 of thecontrol knob 18 are not provided. - Said solution allows reducing the size in height both of the
control knob 18 and of theupper part 2a, thus making theampoule 2 more compact. - Nothing forbids using a threaded coupling with a multiple-
start thread 36 as represented inFigures 9a, 9b and 9c instead of a wide-radiusexternal thread 36 with an almost similar operation. - In said Figures a lower portion sector 4' is further shown, below the
selection side windows 24, having height HI, which is greater than the dimension H present in the described embodiments. Said dimension variation allows both strengthening such a sector and obtaining a better selection of the size of the particles, which can have more reduced size. - Furthermore, in
Figure 9c an enlarged sectional view of aprotuberance 39 on the lower portion sector 4' close to theupper portion 3 is also visible. Saidprotuberance 39, as visible, houses locking wings 40 adapted to block the rotation of thecommand shaft 17 within the threadedportion 34 of the shieldingselector 15 once the desired shielding position has been reached. - In the following the operation of the
nebulization device 1 according to the invention will be described, considering, for illustrative purpose, the above described embodiments. - In particular, reference is made to
Figures 2a, 2b and 2c for the first embodiment and toFigures 5a, 5b and 5c for the second embodiment. - Once the
ampoule 2 of thenebulization device 1 has been filled in with medical fluid and assembled, the operation of the components also present in the prior art does not result to be varied. - Therefore, the intake of pressurized gas through the
nozzle duct 9 and theatomizer 14 occurs. - Simultaneously, through the
entry windows 19 the intake of external air within theampoule 2 occurs. - Therefore, the nebulization of the medical fluid occurs, which is inhaled by the patient through the
mouthpiece 13 connected to theemission duct 12. - According to the invention, through the
command shaft 17, the shieldingselector 15 and theselection side windows 24 the required granulometry can be obtained. - Through the rotation of the
control knob 18 and the consequent sliding of the engagingpins 22 within thecam groove 21, there occurs a rotary-translational movement of the control knob and jointly of thecommand shaft 17. - Thus, the movement of the shielding
selector 15 and of the shielding means 16 is thus allowed. - As seen, the present embodiments provide three selection positions, to each of which the correct granulometry for the respiratory tract affected by the specific patient's therapy corresponds.
- This does not exclude that it is possible to provide a greater number of positions to specify even more a tract to which a therapy can be addressed, without departing from the object of the present invention defined by the appended claims.
- The three illustrated selection positions correspond, in this case, to:
-
position 1, as illustrated inFigures 2a ,5a : a total opening of theselection side windows 24 by the shielding means 16 of the shieldingselector 15; -
position 2, as illustrated inFigures 2b ,5b : a partial opening of theselection side windows 24 by the shielding means 16 of the shieldingselector 15; -
position 3, as illustrated inFigures 2c ,5c : a total occlusion of theselection side windows 24 by the shielding means 16 of the shieldingselector 15. - In this way, there are obtained, respectively:
- large particles for the treatment of the upper respiratory tracts;
- particles suitable for the tracheo-bronchial tract treatment;
- fine particles for the treatment of pulmonary alveoli.
- In particular, experiments performed by the Applicant have shown that the
ampoule 2, according to the configuration, allows obtaining a dimensional difference of MMAD (Mass Median Aerodynamic Diameter) of the particles which varies: - by about 30 - 50% between
position 1 andposition 2, and - by about 150 - 200% between
position 1 andposition 3. - Surely, the delivery speeds also differ markedly, indicatively by the same variation value cited for the dimensions of the particles.
- Using the second embodiment illustrated in
Figure 4 and previously described, through the use of theadditional entry windows 27 on the shieldingselector 15, the flow area for the air entering theampoule 2 is varied. - Clearly, the greater or smaller dimension of the flow area and therefore the greater or lesser consistency of the air flow affects both the delivery speed and the size of the aerosol particles generated by the
ampoule 2. - Furthermore, in the second embodiment illustrated in
Figure 4 , the replacement of the truncated-conical portion 5 instead of a sharp reduction in diameter between theupper portion 3 and thelower portion 4 of theupper component 2a may also affect the performance of theampoule 2. - Advantageously, the described nebulization device allows the formation of a medical aerosol having different granulometries. In this way the
nebulization device 1 according to the invention allows being universally optimized for all the required therapies, whether they are directed to the upper respiratory tracts, to the tracheo-bronchial tract, or more internally to the pulmonary alveoli. - Further advantageously, this can be simply obtained by rotating a
control knob 18 by a predetermined quantity, thus reaching the correct level of shielding of the flow exiting from theatomizer 14. - Furthermore, advantageously, the
nebulization device 1 is completely disassemblable. Therefore, the practicality of the cleaning, disinfection and sterilization phases of thenebulization device 1 components is improved. In fact, with respect to the prior art, embedded, hidden or difficult to reach components are not present, as above described. In this way the hygiene required for a medical device and the prevention of the proliferation of germs, bacteria and viruses are ensured. - Still advantageously, the disassemblability feature is inherently connected to the substitutability feature. It is in fact possible, in case of malfunction or damage to one of the components, to only replace the malfunctioning or damaged component.
- A skilled person will also understand how the
nebulization device 1 according to the invention is practical to use by any patient, without the possibility to incur errors which could make the therapy ineffective. - Still advantageously, the components of the
nebulization device 1 are made of materials suitable for the purpose, both in terms of nebulization and in terms of strength, easy availability and lastly, they are not overly expensive. - The skilled person will understand that the embodiment described can be subjected to various changes and variations, according to specific and contingent needs, all included within the scope of protection of the invention, as defined by the following claims.
Claims (12)
- Nebulization device (1) for medical mixture, of the type comprisinga containing ampoule (2) for said medical mixture, comprising an upper component (2a) and a lower component (2b) connected to each other;at least one emission opening (11) of said nebulized medical mixture from said ampoule (2), andat least one entry window (19) for the intake of air within said ampoule (2);at least one atomizer (14) for the intake of pressurized gas, within said lower component (2b) of said ampoule (2),said atomizer (14) being surmounted by said upper component (2a)at least one, preferably two selection side windows (24) on said upper component (2a), an opening of said selection side windows (24) being shielded by shielding means (16), moved by a command shaft (17)characterized in that said shielding means (16) are axially moved by said command shaft (17) through a shielding selector (15) coupled and linked to a control knob (18) connected to said command shaft (17) such to control the flow coming from the atomizer (14); the coupling between said command shaft (17) and said shielding selector (15) being obtained by a threaded coupling.
- Nebulization device, according to claim 1, wherein said command shaft (17) is connected at one end (32) of a skirt shaped shielding selector (15) comprising said shielding means (16).
- Nebulization device, according to claim 1 or 2, wherein said command shaft (17) extends along a central axis of said upper component (2a).
- Nebulization device, according to any one of claims 1 to 3, wherein said shielding means (16) consists in at least two bulkheads which develop parallel to a longitudinal development of said ampoule (2), at said selection side windows (24).
- Nebulization device, according to any one of claims 1 to 4, wherein said shielding selector (15) further comprises two additional entry windows (27) for the intake of air within said ampoule (2).
- Nebulization device, according to any one of claims 1 to 5, wherein said control knob (18) placed at one end (33) of said command shaft opposite to said shielding selector (15), varies a vertical position of said command shaft (17) through a rotary-translational movement.
- Nebulization device, according to any one of claims 1 to 6, wherein said control knob (18) provides a cam groove (21) at an outer surface (20) thereof, which can be coupled to corresponding engaging pins (22) at an inner surface (23) of said upper component (2a).
- Nebulization device, according to any one of claims 1 to 7, further comprising at least one valve system (25) at a base of said control knob (18) for a flow variation of air flow into the inhalation and exhalation phases.
- Nebulization device, according to any one of claims 1 to 7, characterized by providing a virtual valve system (37) wherein said at least one entry window (19) is wolf-mouth-shaped for adjusting the air flow entering and exiting from said ampoule (2) into the inhalation and exhalation phases.
- Nebulization device, according to any one of claims 1 to 7 wherein said shielding selector (15) is provided with a threaded portion (34) protruding upward, provided of an inner thread (35), such inner thread (35) being engaged by at least one wide-radius external thread (36) obtained on an external surface (38) of said command shaft (17), to shield the opening of said selection side windows (24).
- Nebulization device, according to any one of claims 1 to 9, further comprising a duct segment (12) for the coupling with a mouthpiece (13) at said at least one emission opening (11).
- Nebulization device, according to claim 10 further comprising rotation locking wings (40) for said command shaft (17) within said threaded portion (34).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL18739559T PL3655075T3 (en) | 2017-07-19 | 2018-07-18 | Nebulization device for medical mixture |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102017000082273A IT201700082273A1 (en) | 2017-07-19 | 2017-07-19 | Spray device for a medical mixture |
PCT/EP2018/069492 WO2019016257A1 (en) | 2017-07-19 | 2018-07-18 | Nebulization device for medical mixture |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3655075A1 EP3655075A1 (en) | 2020-05-27 |
EP3655075B1 true EP3655075B1 (en) | 2021-12-29 |
Family
ID=60990928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18739559.5A Active EP3655075B1 (en) | 2017-07-19 | 2018-07-18 | Nebulization device for medical mixture |
Country Status (7)
Country | Link |
---|---|
US (1) | US11389602B2 (en) |
EP (1) | EP3655075B1 (en) |
CN (1) | CN111032132B (en) |
AU (1) | AU2018304889A1 (en) |
IT (1) | IT201700082273A1 (en) |
PL (1) | PL3655075T3 (en) |
WO (1) | WO2019016257A1 (en) |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU32636A1 (en) * | 1953-01-31 | 1900-01-01 | ||
DE1813993C3 (en) * | 1968-12-11 | 1974-01-24 | Paul Ritzau Pari-Werk Kg, 8135 Soecking | Device for atomizing and atomizing liquid or powdery substances |
ES2029248T3 (en) * | 1986-09-22 | 1992-08-01 | Omron Tateisi Electronics Co. | SPRAYER. |
US4976259A (en) * | 1986-12-22 | 1990-12-11 | Mountain Medical Equipment, Inc. | Ultrasonic nebulizer |
US4886055A (en) * | 1988-01-22 | 1989-12-12 | Hoppough John M | Nebulizer device |
GB9422821D0 (en) * | 1994-11-11 | 1995-01-04 | Aid Medic Ltd | Atomizer |
DE19520622C2 (en) * | 1995-06-06 | 2003-05-15 | Pari Gmbh | Device for atomizing fluids |
US5584285A (en) * | 1995-06-07 | 1996-12-17 | Salter Labs | Breathing circuit apparatus for a nebulizer |
US6044841A (en) * | 1997-08-29 | 2000-04-04 | 1263152 Ontario Inc. | Breath actuated nebulizer with valve assembly having a relief piston |
CA2885596A1 (en) * | 2001-03-20 | 2002-09-26 | Trudell Medical International | Nebulizer apparatus with an adjustable fluid orifice |
US20090071470A1 (en) * | 2007-09-18 | 2009-03-19 | Robert Abrams | Emergency medication dose nebulizer |
US20090151716A1 (en) * | 2007-09-18 | 2009-06-18 | Robert Abrams | Semi-automatic emergency medication dose nebulizer |
US7814902B2 (en) * | 2007-09-18 | 2010-10-19 | Robert Abrams | Semi-automatic emergency medication dose nebulizer |
US7836885B2 (en) * | 2007-09-18 | 2010-11-23 | Robert Abrams | Semi-automatic emergency medication dose nebulizer |
ITBS20090030U1 (en) * | 2009-10-15 | 2011-04-16 | Flaem Nuova Spa | TWO-SPEED AMPOLLA DELIVERY FOR AEROSOLTERAPY APPLIANCES |
US8596263B2 (en) * | 2009-11-16 | 2013-12-03 | Samuel David Piper | Inhalation actuated nebulizer with impingement shield |
TWM388940U (en) * | 2010-04-16 | 2010-09-21 | Atlantean Corp | Press-type medical spray generator and pressing mechanism thereof |
JP2012000144A (en) * | 2010-06-14 | 2012-01-05 | Omron Healthcare Co Ltd | Nebulizer kit and nebulizer |
US9757528B2 (en) * | 2010-08-23 | 2017-09-12 | Darren Rubin | Nebulizer having different negative pressure threshold settings |
TWM411285U (en) * | 2011-01-12 | 2011-09-11 | Atlantean Corp | Press-type medical spray generator and pressing mechanism |
JP6035738B2 (en) * | 2011-12-27 | 2016-11-30 | オムロンヘルスケア株式会社 | Nebulizer and nebulizer kit |
JP2013132473A (en) * | 2011-12-27 | 2013-07-08 | Omron Healthcare Co Ltd | Nebulizer and nebulizer kit |
CN202777335U (en) * | 2012-08-31 | 2013-03-13 | 优盛医学科技股份有限公司 | Medicament spray can |
US9539408B2 (en) * | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
EP2952219A1 (en) * | 2014-06-06 | 2015-12-09 | 3A Health Care S.R.L. | Device for atomizing one or more substances |
EP3017839A1 (en) * | 2014-11-10 | 2016-05-11 | Elettroplastica S.p.A. | A device for nebulising substances for aerosols |
CN104958814A (en) * | 2015-07-03 | 2015-10-07 | 江苏鹿得医疗电子股份有限公司 | Novel atomizing cup capable of adjusting atomizing particles |
CN205456070U (en) * | 2016-02-26 | 2016-08-17 | 深圳市合元科技有限公司 | Liquid atomizer can be annotated and electron cigarette of this atomizer is used |
-
2017
- 2017-07-19 IT IT102017000082273A patent/IT201700082273A1/en unknown
-
2018
- 2018-07-18 AU AU2018304889A patent/AU2018304889A1/en not_active Abandoned
- 2018-07-18 WO PCT/EP2018/069492 patent/WO2019016257A1/en unknown
- 2018-07-18 CN CN201880048033.XA patent/CN111032132B/en active Active
- 2018-07-18 US US16/632,708 patent/US11389602B2/en active Active
- 2018-07-18 PL PL18739559T patent/PL3655075T3/en unknown
- 2018-07-18 EP EP18739559.5A patent/EP3655075B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111032132A (en) | 2020-04-17 |
EP3655075A1 (en) | 2020-05-27 |
IT201700082273A1 (en) | 2019-01-19 |
US11389602B2 (en) | 2022-07-19 |
US20210162142A1 (en) | 2021-06-03 |
AU2018304889A1 (en) | 2020-01-30 |
WO2019016257A1 (en) | 2019-01-24 |
CN111032132B (en) | 2022-03-25 |
PL3655075T3 (en) | 2022-04-19 |
RU2020100923A (en) | 2021-08-23 |
RU2020100923A3 (en) | 2021-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200306468A1 (en) | Oscillating positive respiratory pressure device | |
JP6784797B2 (en) | Respiratory therapy device | |
JP3494669B2 (en) | Powder inhaler | |
ES2429867T3 (en) | Nebulizer apparatus | |
CN106461493B (en) | Pressure indicator for oscillating positive expiratory pressure device | |
CA3134083C (en) | Oscillating positive respiratory pressure device | |
US5617844A (en) | Aerosol medication delivery system | |
TWI432232B (en) | Metered liquid droplet inhaler | |
RU2757077C2 (en) | Device for the administration of inhaled drugs in the form of dry powder with dosing resistance mechanism through replaceable nozzles | |
WO1995024938A1 (en) | Resuscitator | |
EP3810240A1 (en) | Respiratory therapy devices and assemblies | |
EP3655075B1 (en) | Nebulization device for medical mixture | |
EP3017839A1 (en) | A device for nebulising substances for aerosols | |
RU2771733C2 (en) | Spraying device for medical mixture | |
RU2630598C1 (en) | Inhaler bottle for aerosol therapy | |
CN219681378U (en) | Novel atomizer | |
CN220833786U (en) | Novel medicine atomizing inhaler | |
CN211050555U (en) | Device for treating respiratory diseases | |
CA3019719A1 (en) | Improved adapter for drug delivery | |
Ocal et al. | NIV Aerosol Therapy: Key Technical Determinants and Clinical Evidence | |
MX2013010368A (en) | Metered dose inhaler port for ventilated patients. | |
WO2010100557A1 (en) | Catheter mount | |
IT201800002179U1 (en) | SPACER OR SPACER EQUIPPED WITH VALVE DEVICE FOR INHALING BRONCOPULMONARY ANTISPASTIC DRUGS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200116 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210601 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20211027 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1458206 Country of ref document: AT Kind code of ref document: T Effective date: 20220115 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602018028820 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220329 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20211229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220329 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220330 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220429 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220429 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602018028820 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220718 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180718 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240620 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240619 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20240621 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20240619 Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 1458206 Country of ref document: AT Kind code of ref document: T Effective date: 20211229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211229 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240619 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20240620 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240718 Year of fee payment: 7 |